FOLH1 and cancer: The aptamer-Dox physical complexes also confirmed stability and higher target activity in cell culture mediums, and growth inhibition analysis (MTT analysis) showed that the aptamer-Dox physical complex releases Dox molecules within lymph node carcinoma of the prostate cells after infusion and kills PSMA-positive cancer cells more efficiently.